HbA1c - An analyte of increasing importance

Clinical Biochemistry

Volumn 45, Issue 13-14, 2012, Pages 1038-1045

  Higgins, Trefor ^a  

^a DynaLIFE   (Canada)

Author keywords

Diabetes mellitus; Glycated hemoglobin; HbA1c

Indexed keywords

ASCORBIC ACID; ERYTHROPOIETIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2A PLUS RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; VITAMIN D;

ANALYTIC METHOD; BLOOD GLUCOSE MONITORING; CALIBRATION; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; ERYTHROPOIESIS; ETHNICITY; GENDER; GLUCOSE BLOOD LEVEL; GLYCATION; GLYCEMIC CONTROL; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; IRON DEFICIENCY ANEMIA; ORAL GLUCOSE TOLERANCE TEST; POINT OF CARE TESTING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST; SEASONAL VARIATION; SMOKING;

AGE FACTORS; ANEMIA, IRON-DEFICIENCY; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CHEMISTRY TECHNIQUES, ANALYTICAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; REFERENCE VALUES; RISK FACTORS;

EID: 84866040763     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.06.006     Document Type: Review

References (131)

1. Huisman T.H., Martis E.A., Dozy A. Chromatography of hemoglobin types on carboxymethylcellulose. J Lab Clin Med 1958, 52:312-327.
2. Allen D.W., Schroeder W.A., Balog J. Observations on the chromatographic heterogeneity of normal adult and fetal hemoglobin: a study of the effects of crystallation and chromatography on the heterogeneity and isoleucine content. J Am Chem Soc 1958, 80:1628-1634.
3. Arnqvist H., Cederblad G., Hermanss G., Wettre S. Rapid and slow rate of decrease in HbA1a+b and HbA1c during improved glycaemic control. Scand J Clin Lab Invest 1982, 42:265-271.
4. Brookchin R.M., Gallop P.M. Structure of hemoglobin A1c: nature of the N-terminal beta chain blocking group. Biochem Biophys Res Commun 1968, 32:86-93.
5. Rahbar S., Blumenfeld O., Ranney H.M. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 1969, 36:838-843.
6. Bunn H.F., Haney D.N., Gabbay K.H., Gallop P.M. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun 1975, 67:103-109.
7. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976, 295:117-120.
8. Sikaris K. The correlation of hemoglobin A1c to blood glucose. J Diabetes Sci Technol 2009, 3:429-438.
9. Diabetes Research Network Study Group Relationship of A1c to glucose concentrations in children with Type 1 diabetes. Diabetes Care 2008, 31:381-385.
10. 1c: implications for the assessment of glycemic control. Clin Chem 2007, 53:697-901.
11. Tahara Y., Shima K. kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995, 18:440-447.
12. Goldstein DE, Little RR, Wiedmeyer H, England JD, Rohlfling C. Glycated haemoglobin estimation in the 1990s: a review of assay methods and clinical interpretation. In Marshall SM, Home PD, eds. The Diabetes Annual/8. Amsterdam: Elsevier Science B.V:193-212.1994.
13. 1c". Clin Chem Lab Med 2007, 45:1081-1082.
14. 1c. Clin Chem Lab Med 1998, 36:299-308.
15. 1c based on peptide mapping. Clin Chem 1997, 43:1944-1951.
16. 1c in human blood. Clin Chem Lab Med 2002, 40:78-89.
17. Hoelzel W., Weykamp C., Jeppsson J.O., Miedma K., Barr J.R., Goodall I., et al. IFCC reference system for measurement of haemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden. Clin Chem 2004, 50:166-174.
18. The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, the International Diabetes foundation Consensus statement on the world wide standardization of the hemoglobin A1c measurement. Diabetes Care 2007, 30:2399-2400.
19. 1c into average blood glucose; implications for clinical chemistry. Clin Chem 2008, 54:1756-1758.
20. Barth J.H., Der R.I., Saudek C.D. A randomized comparison of the terms estimated average glucose versus hemoglobin A1C. Diabetes Educ 2009, 35:596-602.
21. Nathan D.M., Kunen J., Borg R., Zheng H., Schoenfield D., Heine R.J. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31:1-6.
22. 1c. Clin Chem 2010, 56:545-546.
23. Young I.S. The reporting of estimated glucose with hemoglobin A1c. Clin Chem 2010, 54:547-549.
24. Kilpatrick E.S. Estimated average glucose (eAG) fit for purpose?. Diabetes Med 2008, 25:899-901.
25. Canadian Society of Clinical Chemists Position statement. Hemoglobin A1c Measurements and Reporting March 2010.
26. Barth J.H., Marshall S.M., Watson I.D. Consensus meeting on reporting glycated haemoglobin (HbA1c) and estimated average glucose (eAG) in the UK; report to the National Director of Diabetes, Department of Health. Diabet Med 2008, 25(38):1-2.
27. 1c measurements with five current assay methods. J Diabetes Sci Technol 2007, 1:136-142.
28. 1c F, C, and S, with indication for acetlyation or carbamylation by cation-exchange chromatography. Clin Chem 1993, 39:2514-2518.
29. Sacks D.B., Arnold M., Bakris G.L., Bruns D.E., Horvath A.R., Kirkman M.S., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011, 57:e1-e47.
30. 1c from filter papers for population-based studies. Clin Chem 2011, 57:577-585.
31. 1c with varied postcollection conditions. Clin Chem 2009, 55:1034-1036.
32. 1c analysis - precision, accuracy and standardization. Clin Chem Lab Med 2007, 45:1083-1097.
33. 1c: a 4 year experience in Taiwan and the Asia Pacific region. Clin Chem 2009, 55:1876-1880.
34. 1c measurement in IFCC and National Glycohemoglobin Standardization program units are different. Clin Chem 2011, 57:1204-1205.
35. Bruns D.E., Boyd J.C. Few point of care hemoglobin A1c assay methods meet clinical needs. Clin Chem 2010, 56:4-6.
36. 1c point-of care instruments do not meet accepted analytical performance criteria. Clin Chem 2010, 56:44-52.
37. Irvin B., Knaebel J., Simmons D. Assessing the performance of point of care hemoglobin A1c systems. Clin Chem 2010, 56:1359-1360.
38. Lenters-Westra E., Slingerland R.J. Evaluation of the Quo-test hemoglobin A1c point of care instrument: a second chance. Clin Chem 2010, 56:1191-1192.
39. 1c in the management of diabetes; a systematic review and metaanalysis. Clin Chem 2011, 57:568-576.
40. 1c: is performance adequate?. Clin Chem 2011, 57:1333-1334.
41. 1c measurement and goals for improvement; from chaos to order for improving diabetes care. Clin Chem 2011, 57:205-214.
42. 1c measurements. Clin Biochem 2008, 41:88-90.
43. Rohlfling C., Wiedmeyer H.-M., Little R., Grotz V.L., Tennhill A., England J., et al. Biological variation of glycohemoglobin. Clin Chem 2002, 48:1116-1118.
44. Kilpatrick E.S., Maylor P.W., Keevil B.G. Biological variation of glycated hemoglobin. Implications for diabetes and monitoring. Diabetes Care 1998, 21:2205-2208.
45. Braga F., Dolci D., Mosca A., Panteghini M. Biological variability of glycated hemoglobin. Clin Chim Acta 2010, 411:1606-1610.
46. Phillipou G., Phillips P.J. Intraindividual variation of glycohemoglobin: implications for interpreting and analytical goals. Clin Chem 1993, 39:2305-2308.
47. 1c: an international survey. Clin Chem 2005, 51:1145-1153.
48. 1c. Clin Chem 2001, 47:1212-1217.
49. 1c reference ranges. J Diabetes Sci Technol 2009, 3:644-648.
50. The Diabetes Control and Complications Trial research group The effect of intensive treatment of diabetes on the development and progression of long term complications of insulin dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
51. U.K. Prospective Diabetes effect of intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (ULPDS33) U.K. Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:837-853.
52. American Diabetes Association Standards of Medical Care -2012. Diabetes Care 2012, 35:s11-s263.
53. Clinical Practice Guidelines Expert Committee Monitoring gylcemic control. Can J Diabetes 2008, S21-S23.
54. National Institute for Health and Clinical Excellence Type 1 diabetes (CG15) (accessed February 2012). http://guidance.nice.org.uk/(CG15).
55. National Institute for Health and Clinical Excellence Type 2 diabetes (CG66) (accessed February 2012). http://guidance.nice.org.uk/(CG66).
56. Clinical Knowledge Summaries: Type 2 diabetes (accessed February 2012). http://www.cks.uk.diabetes_type2.
57. 1c to screen for Diabetes. J Diabetes Sci Technol 2009, 3:411-417.
58. Salvagno G.L., Lippi G., Targher G., Montagnana M., Guidi G.C. Monitoring glycemic control; Is there sufficient evidence for appropriate use of routine measurements of glycated hemoglobin?. Clin Chem Lab Med 2007, 45:1065-1067.
59. Van Walraven C., Maymond M. Population-based study of repeat laboratory testing. Clin Chem 2003, 49:1997-2005. for the network of Eastern Ontario Medical Laboratories (NEO-MeL0.
60. Wilson S.E., Lipscombe L.L., Rosetta L.C., Manuel D.G. Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: population-based study. BMC Health Serv Res 2009, 9:41.
61. Saudek C.D., Herman W.H., Sacks D.B., Bergenstal R.M., Edelman D., Davison M.B. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008, 93:447-453.
62. International Expert Committee International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
63. Professional Practice Committee Standards of Medical Care in Diabetes -2010. Diabetes Care 2010, 33:s11-s61.
64. American Association of Endocrinologists Board of Directors American College of Endocrinologists Board of Trustees American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of Hemoglobin A1c for the diagnosis of diabetes. Endocr Pract 2010, 16:1555-1556.
65. WHO Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO website. Accessed March 2 2012). http://www.who.int/entity/diabetes/publications/report-hba1c_2011.pdf.
66. Goldberg R.M., Cheung A.Y., Punthakee Z. Use of Glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diabetes 2011, 7:247-248.
67. Sacks D.B. The diagnosis of diabetes is changing: how implementation of hemoglobin A1c will impact clinical laboratories. Clin Chem 2009, 55:1612-1614.
68. Kirkman M.S., Kendall D.M. Hemoglobin A1c to diagnosis diabetes: Why the controversy over adding a new tool?. Clin Chem 2009, 57:255-257.
69. Higgins T.N., Tran D., Cembrowski G.S., Shalapay C., Steele P., Wiley C. Is HbA1c a good screening test for diabetes?. Clin Biochem 2011, 44:1469-1472.
70. Olson D.E., Rhee M.K., Herrick K., Zemer D.C., Tvombly J.G., Phillips L.S. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
71. Ganda O.P., Day J.L., Soeldner J.S., Connon J.J., Gleason R.E. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes 1978, 27:15-25.
72. Santos-Rey K., Fernandez- Riejos P., Mateo J., Sanchez-Margalet V., Gaberna R. glycated hemoglobin vs. the oral glucose tolerance test for the exclusion on impaired glucose tolerance in high-riskindividuals. Clin Chem Lab Med 2010, 48:1719-1722.
73. Ko G.T., Chan J.C., Woo J., Lau E., Yeung V.T., Chow C.C., et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Clin Biochem 1998, 35:62-67.
74. Bruns D.E., Knowler W.C. Stabilization of glucose in Blood samples. Why it matters. Clin Chem 2009, 55:850-852.
75. Bruns D.E., Mikesh L.M. Stabilization of Glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. Clin Chem 2008, 54:930-932.
76. Lorenzo C., Wagenknecht L.W., Hanley A.J., Rewer M.J., Karter A., Haffner S.M. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors. Diabetes Care 2010, 33:2104-2109.
77. Takahshi O., Farmer A.J., Shimbo T., Fukui T., Glaszou P.P. A1C to detect diabetes: When should we recheck?. Diabetes Care 2010, 33:2016-2017.
78. Ginde A.A., Cagliero E., Nathan D.M., Camargo C.A. Point of care glucose and hemoglobin A1C in Emergency department patients without known diabetes; implications for opportunistic screening. Acad Emerg Med 2008, 15:1241-1247.
79. 1c is an independent predictor of nonfatal cardiovascular disease in a Caucasian population without diabetes: a 10 year follow up of the Hoorn Study. Eur J Cardiovasc Prev Rehabil 2012, 19:23-31.
80. Sevin E., Steffes M.W., Zhu H., Matsushita K., Wagenknect L., Pankow J., et al. Glycated hemoglobin, Diabetes, and cardiovascular risk in Nondiabetic adults. N Engl J Med 2010, 362:800-811.
81. Little R.R., Rohlfling C.L., Hanson S., Connolly S., Higgins T.N., Weylamp C.W., et al. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (Hba1c) by 23 methods. Clin Chem 2008, 54:1277-1282.
82. Lee T., Weykamp C.W., Lee Y.-W., Kim J.-W., Ki C.-S. Effects of 7 hemoglobin variants on the measurement of glycohemoglobin by 14 analytical methods. Clin Chem 2007, 53:2002-2005.
83. Bry L., Chan P.C., Sacks D.B. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001, 47:153-163.
84. Frank E.L., Moulton L., Little R.R., Wiedmeyer H.-M., Rohlfing C., Roberts W.L. Effects of hemoglobin C and S traits on 7 glycohemoglobin methods. Clin Chem 2000, 46:864-867.
85. Roberts W.L., De B.K., Hanbury C.M., Hoyer J.D., John W.G., Lambert T.L., et al. Effects of hemoglobin C and S traits on eight glycohemoglobin methods. Clin Chem 2002, 48:383-385.
86. Roberts W.L., Safar-Pour S., De B.K., Rohlfing C.L., Weykamp C.W., Little R.R. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem 2005, 51:776-778.
87. Roberts W.L. Hemoglobin Constant Spring can interfere with glycated hemoglobin measurements by boronate affinity chromatography. Clin Chem 2007, 53:142-143.
88. 1c methods compared with the IFCC reference method. Am J Clin Pathol 2008, 129:811-814.
89. 1c analysis and reporting: an interesting case illustrating the many pitfalls. Clin Biochem 2008, 41:1104-1106.
90. 1c analyses - common practice in clinical laboratories. Clin Chim Acta 2009, 406:124-128.
91. Pani L.N., Korenda L., Meigs J.B., Driver C., Charmany S., Fox C.S., et al. Effect of aging on A1C levels without diabetes: evidence from the Framingham Offspring study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008, 31:1991-1996.
92. Arentz B.B., Kallner A., Theowell T. The influence of aging on haemoglobinA1c (HbA1c). J Gerontol 1982, 37:648-650.
93. 1c in a working male Japanese population. Diabetes Care 1995, 18:1337-1340.
94. Yang Y.C., Lu F.H., Wu J.S., Chang C.J. Age and sex effects on HbA1c: a study in a healthy Chinese population. Diabetes Care 1997, 20:988-991.
95. Polena S.V., Lasseree V., Fonfrede M., Delattre J. Benazeth. A different approach to analyzing age-related HbA1c values in non-diabetic subjects. Clin Chem Lab Med 2004, 42:423-428.
96. Arentz B.B., Kallner K., Roberts N.B. Age does not influence levels of HbA1c in normal subject. Q J Med 1999, 92:169-173.
97. Hanberger L., Samuelsson U., Lindblad B., Ludvigsson J. A1C in children and adolescents with diabetes in relation to certain clinical parameters. The Swedish childhood registry, SWEDIABKIDS. Diabetes Care 2008, 31:927-929.
98. Dilli D., Bostanci I., Dallar Y., Gǜcǜk S. Glycohemoglobin screening in adolescents attending to the department of paediatrics at a tertiary hospital in Turkey. Diabetes Res Clin Pract 2008, 79:305-309.
99. Parikh A., Lipsitz S., Natarajan S. Gender differences in the effect of hemoglobin A1c on mortality in adults with diabetes: findings from a national population based follow up. Circulation 2008, 118S:1134. (abstract).
100. Cohen R.M. A1C. Does one size fit all?. Diabetes Care 2007, 30:2756-2758.
101. Herman W.H., Ma Y., Owaifo G., Hafner S., Khan S.E., Horton E.S., et al. Differences in A1c by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30:2453-2457.
102. Kirk J.K., Passmore L.V., Bell R.A., Narayan K.M., D'Agostino R.B., Arcury T.A., et al. Disparities between Hispanic and non-Hispanic white adults with diabetes: a meta analysis. Diabetes Care 2008, 31:240-246.
103. De Rekeneire N., Rooks R.N., Simonsick E.M., Shorr R.I., Kuller L.H., Schwartz A.V., et al. Health, aging and body composition in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition Study. Diabetes Care 2003, 26:1986-1992.
104. Adams A.S., Khang F., Mah C., Grant R.W., Kleinman K., Meiges J.B., et al. Race differences in long-term diabetes management in a HMO. Diabetes Care 2005, 28:2844-2849.
105. Ishi H., Suzuki H., Baba T., Nakamura K., Watanabe T. Seasonal variation of glycemic control in Type 2 diabetic patients. Diabetes Care 2001, 24:1503.
106. 1c levels without weight change in male patients with Type 2 diabetes treated with insulin. Diabetes Care 2004, 27:1238-1239.
107. 1c in adult patients. Diabetes Care 1997, 20:234.
108. Norfeldt S., Ludvigsson J. Seasonal variation in intensive treatment of children with Type 1 diabetes. J Pediatr Endocrinol Metab 2000, 13:429-435.
109. 1c in patients with Type 2 diabetes mellitus. Diabet Med 2000, 17:554-555.
110. Tseng C.L., Brimacombe M., Xie M., Rajan M., Wang H., Kolassa J., et al. Seasonal patterns in monthly A1c values. Am J Epidemiol 2005, 161:565-574.
111. Gaarde H., Hansen A.M., Skovgaard L.T., Christensen J.M. Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A1c, IgA, prolactin and free testosterone in healthy women. Clin Chem 2000, 46:551-559.
112. Higgins T., Saw S., Sikaris K., Wiley C.L., Cembrowski C.S., Aw Lyon, et al. Seasonal variation in hemoglobin A1c: is it the same in both hemispheres?. J Diabetes Sci Technol 2009, 3:668-671.
113. Chen H.S., Jap T.S., Chen R.L., Lin H.D. A prospective study of glycemic control during holiday time in Type 2 diabetes patients. Diabetes Care 2004, 27:326-330.
114. Hawkins R.C. Circannual variation in glycohemoglobin in Singapore. Clin Chim Acta 2010, 411:18-21.
115. Khera P.K., Joiner C.H., Carruthers A., Lindsell C.J., Smith E.P., Franco R.S., et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 2008, 57:2445-2452.
116. Hempe J.M., Gomez R., McCarter R.J., Chalew S.A. High and low hemoglobin phenotype in type 1 diabetes: A challenge for interpretation of glycemic control. J Diabetes Complications 2002, 16:313-320.
117. Am Syrjälä, Yiöstalo P., Niskanen M.C., Hnuuttila M.L. Role of smoking and HbA1c level in periodontitis among insulin-dependent diabetic patients. J Clin Periodontol 2003, 10:871-875.
118. 1c values and microalbuminuria in patients with diabetes-data from the National Diabetes Register in Sweden. Diabetes Metab 2004, 30:261-268.
119. Coban E., Ozdogan M., Timuragaoglu A. effect t of iron deficiency of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004, 112:126-128.
120. Kim P.S., Woods C., Georgoff P., Crum D., Rosenberg A., Smith M., et al. hemoglobin A1c underestimates glycemia in HIV infections. Diabetes Care 2009, 32:1591-1593.
121. Greenberg P.D., Rosman A.S., Eldeiry L.S. Decline in haemoglobin A1c values in diabetic patients receiving interferon alpha and ribavirin for chronic hepatitis C. J Viral Hepat 2006, 13:613-617.
122. Gross B.N., Cross L.B., Foard J.C. Falsely low hemoglobin A1c levels in a patient receiving ribavirin and peginterferonalfa-2b for hepatitis C. Pharmacotherapy 2009, 29:121-123.
123. 1c-Good diabetic control?. Clin Chem 2012, 58:648-649.
124. Brown J.N., Kemp D.W., Brice K.R. Class effect of erythropoietin therapy on Hemoglobin A1c in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis. Pharmacotherapy 2009, 29:469-472.
125. 1c). The Tromsø Study. Scand J Clin Lab Invest 2011, 71:399-406.
126. Kositsawat J., Freeman V.L., Gerber B.S., Geraci S. Association of A1C levels with vitamin D status in U.S. adults: data from the National Health and Nutrition Survey. Diabetes Care 2010, 33:1236-1238.
127. Kositsawat J., Freeman V.L. Vitamin C and relationship in the National Health and Nutrition Examination Survey (NHANES) 2003-2006. J Am Coll Nutr 2011, 30:477-483.
128. Davie S.J., Gould B.J., Yudkin J.S. Effects of vitamin C on glycosylation of proteins. Diabetes 1992, 41:167-173.
129. Ceriello A., Giugliano D., Quatraro A., Donzella C., Dipalo G., Lefebvre P.J. Vitamin E reduction of protein glycosylation in diabetes. New prospects for prevention of diabetic complications?. Diabetes Care 1991, 14:68-72.
130. Elder G.E., Lappin T.R.J., Home A.B., Fairbanks V.F., Jones R.T., Winter P.C., et al. Hemoglobin Old dominion/Burton on Trent, β143 (H21) his→tyr, codon 143 CAC→TAC - a variant with altered oxygen affinity that compromises measurement of glycated hemoglobin in diabetes mellitus: structure, Function and DNA sequenc. Mayo Clin Proc 1998, 73:321-328.
131. Gallagher E.J., Bloomgarden Z.T., Roith D. Review of A1c in the management of diabetes. Journal of Diabetes 2009, 1:9-17.